• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

膀胱肌肉浸润性移行细胞癌中10号染色体长臂频繁出现杂合性缺失。

Frequent loss of heterozygosity on chromosome 10q in muscle-invasive transitional cell carcinomas of the bladder.

作者信息

Cappellen D, Gil Diez de Medina S, Chopin D, Thiery J P, Radvanyi F

机构信息

UMR 144, Centre National de la Recherche Scientifique, Institut Curie, Section de Recherche, Paris, France.

出版信息

Oncogene. 1997 Jun 26;14(25):3059-66. doi: 10.1038/sj.onc.1201154.

DOI:10.1038/sj.onc.1201154
PMID:9223669
Abstract

Loss of heterozygosity (LOH) on chromosome 10 has been observed in several human cancers including glioblastomas, meningiomas, melanomas and endometrial and prostate carcinomas. We have investigated the incidence of LOH on chromosome 10 in 36 human transitional cell carcinomas (TCCs) of the bladder, three upper urinary tract TCCs and one lymph node metastasis, using a panel of 27 highly polymorphic markers spanning 10p (short arm) and 10q (long arm). Fourteen bladder tumours (39%), the three upper urinary tract tumours and the lymph node metastasis showed LOH for at least one locus on chromosome 10. Remarkably, LOH on chromosome 10 was observed mainly in muscle-invasive (P = 0.01) and high grade tumours (P = 0.03). For five tumours and the lymph node metastasis, LOH was found at all informative loci, indicating monosomy or isodisomy of chromosome 10. The deletion mapping of the tumours with partial loss delineated two minimal regions of loss on chromosome 10q. One region, the most telomeric, was bounded by markers D10S214 and D10S169 and the other, the most proximal, was bounded by markers D10S222 and D10S531. Our results demonstrate that chromosome 10q LOH is common in muscle-invasive bladder cancers and that two potential tumour suppressor loci, at 10q24.1-q24.3 and 10q26.1-q26.2, may contribute to the malignant progression of these tumours. Localization of the smallest common regions of loss in bladder tumours provides a starting point for the identification of the genes involved.

摘要

在包括胶质母细胞瘤、脑膜瘤、黑色素瘤以及子宫内膜癌和前列腺癌在内的多种人类癌症中,均观察到了10号染色体上的杂合性缺失(LOH)。我们使用一组覆盖10号染色体短臂(10p)和长臂(10q)的27个高度多态性标记,对36例人类膀胱移行细胞癌(TCC)、3例上尿路TCC以及1例淋巴结转移瘤中10号染色体上的LOH发生率进行了研究。14例膀胱肿瘤(39%)、3例上尿路肿瘤以及淋巴结转移瘤在10号染色体上至少有一个位点出现了LOH。值得注意的是,10号染色体上的LOH主要见于肌层浸润性肿瘤(P = 0.01)和高级别肿瘤(P = 0.03)。在5例肿瘤以及淋巴结转移瘤中,在所有信息位点均发现了LOH,提示10号染色体单体性或等二体性。对部分缺失肿瘤的缺失图谱分析确定了10q上两个最小缺失区域。一个区域位于最末端,由标记D10S214和D10S169界定,另一个区域位于最近端,由标记D10S222和D10S531界定。我们的结果表明,10q LOH在肌层浸润性膀胱癌中很常见,并且位于10q24.1 - q24.3和10q26.1 - q26.2的两个潜在肿瘤抑制基因座可能促成了这些肿瘤的恶性进展。膀胱肿瘤中最小共同缺失区域的定位为鉴定相关基因提供了一个起点。

相似文献

1
Frequent loss of heterozygosity on chromosome 10q in muscle-invasive transitional cell carcinomas of the bladder.膀胱肌肉浸润性移行细胞癌中10号染色体长臂频繁出现杂合性缺失。
Oncogene. 1997 Jun 26;14(25):3059-66. doi: 10.1038/sj.onc.1201154.
2
Identification of loci associated with putative recurrence genes in transitional cell carcinoma of the urinary bladder.膀胱移行细胞癌中与假定复发基因相关位点的鉴定。
J Pathol. 2002 Apr;196(4):380-5. doi: 10.1002/path.1052.
3
Loss of heterozygosity at the RB locus is frequent and correlates with muscle invasion in bladder carcinoma.
Oncogene. 1991 Dec;6(12):2305-9.
4
Definition of two regions of deletion on chromosome 9 in carcinoma of the bladder.膀胱癌中9号染色体上两个缺失区域的定义。
Oncogene. 1994 Jul;9(7):2083-8.
5
Evidence for two tumor suppressor loci associated with proximal chromosome 9p to q and distal chromosome 9q in bladder cancer and the initial screening for GAS1 and PTC mutations.与膀胱癌中近端9号染色体p臂至q臂以及远端9号染色体q臂相关的两个肿瘤抑制基因座的证据及GAS1和PTC突变的初步筛查。
Cancer Res. 1996 Nov 1;56(21):5039-43.
6
Deletion mapping of chromosome 8 in cancers of the urinary bladder using restriction fragment length polymorphisms and microsatellite polymorphisms.利用限制性片段长度多态性和微卫星多态性对膀胱癌中8号染色体进行缺失图谱分析。
Oncogene. 1993 May;8(5):1357-64.
7
Evidence for two candidate tumour suppressor loci on chromosome 9q in transitional cell carcinoma (TCC) of the bladder but no homozygous deletions in bladder tumour cell lines.在膀胱移行细胞癌(TCC)中9号染色体长臂上两个候选肿瘤抑制基因座的证据,但膀胱肿瘤细胞系中无纯合缺失。
Br J Cancer. 1999 May;80(3-4):489-94. doi: 10.1038/sj.bjc.6690383.
8
Deletion mapping implicates two tumor suppressor genes on chromosome 8p in the development of bladder cancer.缺失定位表明8号染色体短臂上的两个肿瘤抑制基因与膀胱癌的发生有关。
Oncogene. 1996 Mar 7;12(5):1083-7.
9
[Loss of heterozygosity fine mapping of chromosome 17p13 in transitional cell carcinoma of human urinary bladder].[人膀胱移行细胞癌17号染色体p13区域杂合性缺失的精细定位]
Zhonghua Yi Xue Za Zhi. 2002 Feb 10;82(3):161-3.
10
Allelotype of human bladder cancer.人类膀胱癌的等位基因型
Cancer Res. 1994 Jan 15;54(2):531-8.

引用本文的文献

1
GATA3 amplification is associated with high grade disease in non-invasive urothelial bladder cancer but unrelated to patient prognosis.GATA3基因扩增与非侵袭性膀胱尿路上皮癌的高级别病变相关,但与患者预后无关。
BMC Urol. 2025 Feb 20;25(1):37. doi: 10.1186/s12894-025-01704-y.
2
Hypermethylation of FOXA1 and allelic loss of PTEN drive squamous differentiation and promote heterogeneity in bladder cancer.FOXA1 过度甲基化和 PTEN 等位基因缺失驱动膀胱癌的鳞状分化,并促进其异质性。
Oncogene. 2020 Feb;39(6):1302-1317. doi: 10.1038/s41388-019-1063-4. Epub 2019 Oct 21.
3
Cancer Mutations in FGFR2 Prevent a Negative Feedback Loop Mediated by the ERK1/2 Pathway.
FGFR2 中的癌症突变可阻止由 ERK1/2 通路介导的负反馈回路。
Cells. 2019 May 29;8(6):518. doi: 10.3390/cells8060518.
4
Neuroendocrine Carcinoma of the Kidney and Bladder with Loss of Heterozygosity and Changes in Chromosome 3 Copy Number.伴有杂合性缺失及3号染色体拷贝数改变的肾和膀胱神经内分泌癌
Am J Case Rep. 2015 Sep 11;16:611-6. doi: 10.12659/AJCR.894274.
5
Genetic deletion and pharmacological inhibition of Akt1 isoform attenuates bladder cancer cell proliferation, motility and invasion.Akt1亚型的基因缺失和药理学抑制可减弱膀胱癌细胞的增殖、运动性和侵袭能力。
Eur J Pharmacol. 2015 Oct 5;764:208-214. doi: 10.1016/j.ejphar.2015.06.059. Epub 2015 Jul 3.
6
Is 5´-AMP-Activated Protein Kinase Both Jekyll and Hyde in Bladder Cancer?5´-AMP激活蛋白激酶在膀胱癌中是善恶兼具吗?
Int Neurourol J. 2015 Jun;19(2):55-66. doi: 10.5213/inj.2015.19.2.55. Epub 2015 Jun 29.
7
Molecular biology of bladder cancer: new insights into pathogenesis and clinical diversity.膀胱癌的分子生物学:发病机制和临床多样性的新见解。
Nat Rev Cancer. 2015 Jan;15(1):25-41. doi: 10.1038/nrc3817.
8
Biomarkers for bladder cancer management: present and future.膀胱癌管理的生物标志物:现状与未来。
Am J Clin Exp Urol. 2014 Apr 5;2(1):1-14. eCollection 2014.
9
CSTP1, a novel protein phosphatase, blocks cell cycle, promotes cell apoptosis, and suppresses tumor growth of bladder cancer by directly dephosphorylating Akt at Ser473 site.CSTP1,一种新型的蛋白磷酸酶,通过直接将 Akt 丝氨酸 473 位点去磷酸化来阻滞细胞周期、促进细胞凋亡、抑制膀胱癌肿瘤生长。
PLoS One. 2013 Jun 17;8(6):e65679. doi: 10.1371/journal.pone.0065679. Print 2013.
10
Autophagy limits the cytotoxic effects of the AKT inhibitor AZ7328 in human bladder cancer cells.自噬限制 AKT 抑制剂 AZ7328 对人膀胱癌细胞的细胞毒性作用。
Cancer Biol Ther. 2012 Nov;13(13):1325-38. doi: 10.4161/cbt.21793. Epub 2012 Aug 16.